<Suppliers Price>

HUHS015

Names

[ CAS No. ]:
1453097-13-6

[ Name ]:
HUHS015

[Synonym ]:
1H-Pyrazol-5-ol, 3-methyl-1-(6-methyl-1H-benzimidazol-2-yl)-4-(phenylmethyl)-
4-Benzyl-3-méthyl-1-(6-méthyl-1H-benzimidazol-2-yl)-1H-pyrazol-5-ol
4-Benzyl-3-methyl-1-(6-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-5-ol
4-Benzyl-3-methyl-1-(5-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-5-ol
4-Benzyl-3-méthyl-1-(5-méthyl-1H-benzimidazol-2-yl)-1H-pyrazol-5-ol
1H-Pyrazol-5-ol, 3-methyl-1-(5-methyl-1H-benzimidazol-2-yl)-4-(phenylmethyl)-
HUHS015

Biological Activity

[Description]:

HUHS015 is a potent PCA-1/ALKBH3 inhibitor both in vitro and in vivo. The bioavailability (BA) of HUHS015 was 7.2% in rats after oral administration. Continuously administering HUHS015 significantly suppressed the growth of DU145 cells, which are human hormone-independent prostate cancer cells, in a mouse xenograft model without untoward effects. [1]

[Related Catalog]:

Signaling Pathways >> Others >> Others
Research Areas >> Cancer

[References]

[1]. Nakao S et al. Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs. Bioorg Med Chem Lett, 2014 Feb 15, 24(4):1071-4.


[Related Small Molecules]

Captisol | Cyclosporin A | H2DCFDA | 0MPTP hydrochloride | GW4869 | Etomoxir | TD139 | Mitoquinone mesylate | GSK2795039 | JC-1 | BAPTA-AM | AP 20187 | Setanaxib (GKT137831) | D-Luciferin | Crotaline

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
585.2±42.0 °C at 760 mmHg

[ Molecular Formula ]:
C19H18N4O

[ Molecular Weight ]:
318.372

[ Flash Point ]:
307.7±27.9 °C

[ Exact Mass ]:
318.148071

[ LogP ]:
4.72

[ Vapour Pressure ]:
0.0±1.7 mmHg at 25°C

[ Index of Refraction ]:
1.689

[ Storage condition ]:
2-8℃


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.